                         SEQUENCE LISTING

<110>  Palatin Technologies, Inc.
       Yang, Wei
       Shi, Yi-Qun
 
<120>  Melanocortin-1 Receptor-Specific Linear Peptides

<130>  1011-136

<150>  61/263,486
<151>  2009-11-23

<160>  25    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Homo sapiens

<400>  1

His Phe Arg Trp 
1               


<210>  2
<211>  13
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  AMIDATION

<400>  2

Ser Tyr Ser Met Glu His Phe Arg Trp Gly Lys Pro Val 
1               5                   10              


<210>  3
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic analog of SEQ ID NO:2


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  AMIDATION

<400>  3

Ser Tyr Ser Xaa Glu His Xaa Arg Trp Gly Lys Pro Val 
1               5                   10              


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  4

Xaa Ala His Xaa Arg Ala Trp 
1               5           


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  5

Xaa Ala His Xaa Arg Pro Trp 
1               5           


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  AMIDATION

<400>  6

Xaa His Xaa Arg Ala Trp 
1               5       


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Sar

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  7

Xaa Ala His Xaa Arg Xaa Trp 
1               5           


<210>  8
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  8

Xaa Ala His Xaa Arg Gly Trp 
1               5           


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  9

Xaa Ala His Phe Arg Ala Trp 
1               5           


<210>  10
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  10

Xaa Ala His Phe Arg Gly Trp 
1               5           


<210>  11
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  AMIDATION

<400>  11

Xaa His Phe Arg Ala Trp 
1               5       


<210>  12
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-Trp

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  12

Xaa Ala His Xaa Arg Ala Xaa 
1               5           


<210>  13
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  AMIDATION

<400>  13

Xaa Ala Xaa Arg Ala Trp 
1               5       


<210>  14
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-Pro

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  14

Xaa Ala His Xaa Arg Xaa Trp 
1               5           


<210>  15
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-Pro

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-Trp

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  15

Xaa Ala His Xaa Arg Xaa Xaa 
1               5           


<210>  16
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-Trp

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  16

Xaa Ala His Xaa Arg Pro Xaa 
1               5           


<210>  17
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<400>  17

Xaa Ala His Xaa Arg Ala Trp 
1               5           


<210>  18
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  AMIDATION

<400>  18

Xaa Xaa Arg Ala Trp 
1               5   


<210>  19
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  19

Xaa Ala His Xaa Ala Ala Trp 
1               5           


<210>  20
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  20

Xaa Ala Ala Xaa Arg Ala Trp 
1               5           


<210>  21
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  21

Xaa Ala Arg Xaa Arg Ala Trp 
1               5           


<210>  22
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  22

Xaa Ala Phe Xaa Arg Ala Trp 
1               5           


<210>  23
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  23

Xaa Ala Lys Xaa Arg Ala Trp 
1               5           


<210>  24
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  24

Xaa Ala Xaa Xaa Arg Ala Trp 
1               5           


<210>  25
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin-1 receptor-specific peptide of invention


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  25

Xaa Ala Xaa Xaa Arg Ala Trp 
1               5           


